RxDoctor Payments Data

Gregory Houston

Surgical · Birmingham, ALNPI 1003953662

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Baxter Healthcare at 29.7% of the total.

$909in general payments, 2019–2025

Across 22 payments — averaging $41.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$270
  • Smith+Nephew$237
  • Atland Pharmaceuticals, LLC$165
  • Johnson & Johnson$78
  • Convatec Inc.$36
  • Bioventus LLC$20
  • plus $102 from 7 others

What the payments were for

  • Food & beverage$909100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$909 in reported general payments places this provider in the 60th percentile of 162 surgical providers in Alabama.

See all surgical providers in Alabama

Medicare billing

Part B allowed, 2024
$6,596
Medicare patients
33
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib32$842
Doxycycline Hyclate36$377
Diclofenac Sodium21$300
Meloxicam64$263
Cephalexin143$217
Methocarbamol52$205

Paid to pharmacies, not to this prescriber.

Other surgical in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →